President
Christian Max Schmidt MD PhD, MBA
Indianapolis, IN
Dr. C. Max Schmidt, MD, PhD, MBA, FACS, is Professor of Surgery and Professor of Biochemistry and Molecular Biology with tenure at Indiana University School of Medicine. He received his medical and business education at the University of Chicago receiving his MD and MBA in 1992. He completed general surgical residency (2000) as well as pancreaticobiliary fellowship (2001) at Johns Hopkins Hospital. He also received his PhD in Physiology and Biophysics from Georgetown University in 1998. He currently holds national office as the President of the Association for Academic Surgery Foundation (AASF) and recently served three year term as the Treasurer for the Association for Academic Surgery (AAS). He serves/served on several other national surgical organization committees/councils including the Society for University Surgeons (SUS), Society for Surgery of the Alimentary Tract (SSAT), Central Surgical Association (CSA) and the Midwest Surgical Association (MSA). He initiated an international outreach program to teach the fundamentals of surgical research in France and has facilitated the development of a similar program in Australia.
Dr. Schmidt is an attending surgeon at Indiana University Hospital with a practice focused on patients with pancreaticobiliary disease. He is an internationally recognized expert on pancreatic cancer and precancerous cystic lesions of the pancreas serving on a number of international committees including the International Committee which develops the Consensus Guidelines for the Treatment of Cystic Lesions of the Pancreas. He is Surgical Director of the Indiana University Health Pancreas Cyst and Cancer Early Detection Center www.pancyst.org which coordinates the care and follow-up of over 1000 patients with precancerous cystic lesions of the pancreas. He also directs the Robotic Pancreaticobiliary Surgery Program at Indiana University Health and has been performing robotic pancreatic surgery for 8 years. Dr. Schmidt is the Director of Education for Research in the Department of Surgery at Indiana University. Dr. Schmidt performs clinical trials and translational research directed at discovering novel biomarkers and targeted treatments for patients with pancreatic and liver neoplasia.
His research is or has been continuously funded for 13 years. Funding sources have included the National Institutes of Health (NIH), Veteran’s Affairs (VA), American Cancer Society (ACS), American Association for Cancer Research (AACR), Pancreatic Cancer Action Network (PanCAN), Lustgarten Foundation and Bigelow-Brand Charity. He is Founder of the company “B9” which specializes in the development of “benign” biomarkers of disease. In the community, he has a significant following for his clinical and research work as evidenced by the Bigelow-Brand Charity Board which holds two major fundraising events annually, one sponsored by the NCAA, to raise money for his early detection research. Dr. Schmidt was recently featured on the cover of Indianapolis Magazine as a 2012 Top Doc, was a 2013 Finalist for the Indianapolis Business Journal’s Health Care Heroes Award and his Pancreatic Cyst and Cancer Early Detection Center has been recently featured on Channel 8 and 13. He has been happily married for 25 years and has 5 children ages 19, 18, 16, 15, and 8.
You must be logged in to post a comment.